RUSSO, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 5.108
NA - Nord America 3.985
EU - Europa 3.651
SA - Sud America 700
Continente sconosciuto - Info sul continente non disponibili 393
AF - Africa 132
OC - Oceania 6
Totale 13.975
Nazione #
US - Stati Uniti d'America 3.800
SG - Singapore 2.127
RU - Federazione Russa 1.423
IT - Italia 1.235
CN - Cina 1.043
VN - Vietnam 920
BR - Brasile 553
HK - Hong Kong 366
DE - Germania 180
FR - Francia 170
JP - Giappone 138
FI - Finlandia 137
CA - Canada 102
BD - Bangladesh 98
IN - India 93
GB - Regno Unito 88
IE - Irlanda 86
NL - Olanda 77
UA - Ucraina 65
KR - Corea 57
AR - Argentina 51
MX - Messico 42
SE - Svezia 39
CI - Costa d'Avorio 38
PH - Filippine 35
ID - Indonesia 30
ZA - Sudafrica 30
PL - Polonia 29
EC - Ecuador 28
ES - Italia 26
IQ - Iraq 25
PK - Pakistan 24
TR - Turchia 23
AT - Austria 21
TW - Taiwan 21
TH - Thailandia 20
CO - Colombia 16
PT - Portogallo 15
VE - Venezuela 15
MA - Marocco 13
IR - Iran 11
PY - Paraguay 11
CR - Costa Rica 10
UZ - Uzbekistan 10
BG - Bulgaria 9
CL - Cile 9
PE - Perù 9
SA - Arabia Saudita 9
TN - Tunisia 9
EG - Egitto 6
GT - Guatemala 6
KE - Kenya 6
AU - Australia 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
LB - Libano 5
NP - Nepal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
BB - Barbados 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
LT - Lituania 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
BE - Belgio 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
MT - Malta 2
MW - Malawi 2
MZ - Mozambico 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
Totale 13.550
Città #
Singapore 1.041
San Jose 565
Chandler 386
Hong Kong 344
Moscow 336
Beijing 274
Naples 273
Ashburn 252
Ho Chi Minh City 239
Santa Clara 229
Hefei 192
Hanoi 174
Dong Ket 130
The Dalles 128
Napoli 110
Millbury 105
Tokyo 103
Lauterbourg 102
Los Angeles 93
Council Bluffs 91
Rome 72
Nanjing 70
Princeton 70
Orta di Atella 56
Jacksonville 53
Munich 51
Boston 50
Des Moines 50
Redondo Beach 46
Amsterdam 44
Dallas 43
Buffalo 42
Milan 41
São Paulo 41
Ottawa 40
Seoul 38
Turku 38
Wilmington 38
New York 37
Da Nang 36
Haiphong 35
Orem 35
Dublin 29
Helsinki 27
Seattle 24
Lawrence 23
Rio de Janeiro 22
Frankfurt am Main 21
Kochi 21
Shenyang 21
Toronto 21
Biên Hòa 20
Chicago 20
Mexico City 19
Cagliari 18
Warsaw 18
Houston 17
Nuremberg 17
Pozzuoli 17
San Francisco 17
Montreal 16
Hải Dương 15
Tianjin 15
London 14
Atlanta 13
Baghdad 13
Falkenstein 13
Guangzhou 13
Jiaxing 13
Phoenix 13
Redwood City 13
Campinas 12
Chennai 12
Denver 12
Formia 12
Lappeenranta 12
Poplar 12
Bangkok 11
Belo Horizonte 11
Brooklyn 11
Nocera Inferiore 11
Shanghai 11
Can Tho 10
Dhaka 10
Guayaquil 10
Hebei 10
Nanchang 10
Vienna 10
Bologna 9
Brasília 9
Norwalk 9
Quito 9
Stockholm 9
Bagnoli Irpino 8
Boardman 8
Caserta 8
Goiânia 8
Palermo 8
Salerno 8
Santo André 8
Totale 7.004
Nome #
- T.M. Devlin, Biochimica con aspetti clinico-farmaceutici, EdiSES, 2013 231
Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma 215
Vitamin C enhanced erastin-induced ferroptosis in drug-resistant colorectal cancer cells and in CAM-derived xenografts 183
Cysteine Prevents the Reduction in Keratin Synthesis Induced by Iron Deficiency in Human Keratinocytes 170
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 168
Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells 167
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 164
Antiproliferative Effects of the Aptamer d(GGGT) 4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells 160
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 160
The ‘‘Janus face” of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modifications 152
TITOLO: ANTICORPO ANTI CISTATIONINA BETA SINTASI FOSFORILATA E USO DELLO STESSO 151
Backbone modified TBA analogues endowed with antiproliferative activity 149
Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP 148
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 147
Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells 147
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 144
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 144
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 143
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays 143
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 142
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 141
UL3 mediated nucleolar stress pathway as a new mechanism of action of antiproliferative G-quadruplex TBA derivatives in colon cancer cells 141
β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide 140
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 140
Novel extraribosomal function of human ribosomal protein rpL3 139
"Alternative splicing and nonsense-mediated mRNA decay (NMD) in the regulation of mammalian ribosomal protein expression 138
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 136
cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins 136
BIOCHIMICA III EDIZIONE 135
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53 134
Photo-control of cancer cell growth by benzodiazoN-substituted pyrrole derivatives 134
Role of rpL3 in the translational reprogramming of colon cancer cells resistant to 5-FU” 133
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 133
Ribosome-free L3 targets E2F pathway: a new p53 independent mechanism linking ribosomal stress to cancer cell proliferation 132
Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives 132
Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer 131
Engineering of seminal RNase: first steps towards the construction of chimaeric ribonucleases. In: Structure, mechanism and functions of ribonucleases. 131
Therapeutic Approaches Targeting Nucleolus in Cancer. 130
Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner 128
Monomolecular G-quadruplex structures with inversion of polarity sites: new topologies and potentiality 128
G-Quadruplex aptamer T30175 and its derivatives: exploring new potential anticancer activities 127
Human rpL3 induces p21-dependent G1/S arrest or apoptosis in Calu-6 cells 126
Alternative splicing of ribosomal protein genes regulated by AS-NMD association 125
Enhanced 5-FU-mediated activation of p53-dependent nucleolar stress by MDM2/4 peptide inhibitors in colon cancer cells 124
Ribosomal protein uL3 status affects translation efficiency in colorectal cancer cells 123
Fetal Myosin Isoforms May Predict Postoperative Outcome of Patients Undergoing Congenital Heart Surgery: A Proof-of-Concept Study 122
Human rpL3 induces mitochondrial apoptosis in Calu-6 cells through activation of p21 expression. 122
Combination of 5-FU and MDM2/4 peptide inhibitors as a promising strategy to enhance 5-FU induced nucleolar stress. 121
Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier 121
MDM2/4 inhibitors as novel therapeutic strategy to enhance 5-FU induced nucleolar stress and apoptosis in colon cancer cells 120
Novel extraribosomal function of human ribosomal protein rpL3 120
Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells 120
Role of autophagy in cancer cell response to nucleolar and endoplasmic reticulum stress 120
A novel extraribosomal function of human rpL3 involves antitumoral activity in Calu-6 cells through p21-dependent mitochondrial apoptosis 119
A novel extraribosomal function of human rpL3 involves antitumoral activity in Calu-6 cells through p21-dependent mitochondrial apoptosis. 117
Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG2T(G3T)3] and Its Derivatives with an Abasic Site Replacing Single Thymidine 117
Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles 116
Cystine/glutamate exchanger xCT plays a critical role in uL3-mediated drug resistance 115
Subcellular localization of mRNAs encoding human ribosomal proteins 112
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation 111
Biologically active recombinant Prothrombin and Antithrombin III expressed in a human hepatoma/vaccinia virus system. 111
Ribosomal protein L7a binds RNA through two distinct RNA-binding domains 111
Effect of phytocannabinoids in "in vitro models of Alzheimer's Disease" 111
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 110
Human rpL3 induces mitochondrial apoptosis in Calu-6 cells through activation of p21 expression 110
Gene modulation by tumor promoters. 109
PEGylated cationic nanoassemblies based on triblock copolymers to combine siRNA therapeutics with anticancer drugs 109
Easy chemical modifications to explore the ‘Janus face’ of TBA: anticoagulant vs antiproliferative properties. 107
Ribosome biogenesis and cancer: Overview on ribosomal proteins 107
Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release:role of mast cell protease-5 106
Degradazione selettiva di mRNA aberranti nella regolazione dell'espressione genica 106
L3 is involved in the translational reprogramming in 5-FU chemoresistance” ABCD Meeting: From Stress Response to Tissue Development and Regeneration. 105
Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting 104
S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation 102
Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin. 102
Different domains cooperate to target the human ribosomal L7a protein to the nucleus and to the nucleoli. 102
Control of human coagulation by recombinant serine proteases. 102
Post-transcriptional regulatory strategies and extraribosomal functions of human rpL3 102
hnRNP H1 and intronic G-runs in the splicing control of the human rpL3 gene FEBS 102
Ribosome-free L3 regulates cell proliferation independently of p53 by targeting E2F and inhibiting its function 102
S-Adenosyl-L-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells 101
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 101
β-carotene as a novel adjuvant in the therapy with 5-FU of p53 deleted colon cancer cells 98
Association of alternative splicing (AS) and nonsense-mediated mRNA decay (NMD) in the post-transcriptional regulation of ribosomal protein genes 98
Nanoparticles sequentially decorated with polyethyleneimine and hyaluronan delivering drugs to cancer cells overexpressing CD44 receptor 97
rpL3 mediates the cell response to nucleolar stress induced by Act D in p53 null cancer cells 97
Biodegradable nanoparticles bearing amine groups as a strategy to alter surface features, biological identity and accumulation in a lung metastasis model 97
Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53 96
uL3 is a key regulator of oxidative stress response genes in multidrug resistant lung cancer cells 96
ALTERNATIVE SPLICING AND NONSENSE-MEDIATED MRNA DECAY REGULATE MAMMALIAN RIBOSOMAL GENE EXPRESSION 95
Palmitoylethanolamide controls rMCP-5 activity by the regulation of microphtalmia-associated transcription factor. 95
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-b-synthase in colon cancer cells lacking p53 95
S-Adenosyl-l-Methionine: a strategy for overcoming uL3-mediated drug resistance in p53 deleted colon cancer cells 93
The 3'-untranslated region directs ribosomal protein-encoding mRNAs to specific cytoplasmic regions 90
AS-NMD in ribosomal protein gene regulation: involvment of hnRNP H1. KHSRP and Nucleophosmin/NMP 90
Easy chemical modifications to explore the ‘Janus face’ of TBA: anticoagulant vs antiproliferative properties. 90
Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress 88
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 88
Impact of ribosomal protein uL3 status on cystine/glutamate antiporter xCT expression 87
HUMAN L7A RIBOSOMAL PROTEIN: SEQUENCE, STRUCTURAL ORGANIZATION AND EXPRESSION OF A FUNCTIONAL GENE 86
Totale 12.316
Categoria #
all - tutte 42.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022497 0 4 6 9 7 40 6 16 76 30 82 221
2022/2023867 106 85 22 78 89 111 5 99 163 43 44 22
2023/2024471 28 81 38 11 20 50 23 74 11 13 74 48
2024/20253.750 130 208 15 185 157 244 425 245 272 315 1.221 333
2025/20266.529 672 628 685 592 1.150 201 605 456 802 409 180 149
2026/2027260 194 66 0 0 0 0 0 0 0 0 0 0
Totale 13.975